top of page
Report Summary
Market Overview

Global Bovine Mastitis Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Bovine Mastitis Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Type (Clinical Mastitis, and Sub-clinical Mastitis), Product (Antibiotics, Surgery, Vaccines, Pain Killers, and Other Products), Route of Administration (Intra-mammary, and Systemic), Therapy (Lactating Period, and Dry Period), End User (Hospitals and Clinics, Veterinary Centers, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Market Overview


The Global Bovine Mastitis Market was valued at USD 2,010.7 million in 2023 and is expected to reach USD 2,859.4 million by 2031 while growing at a CAGR of 4.5% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global bovine mastitis Market growth. Bovine mastitis, an inflammation of the mammary gland in cows, stems from factors like bacterial infection, environmental issues, or injury. This condition, impactful in the dairy industry, detrimentally influences milk production, quality, and overall animal health. It can manifest as acute or chronic, affecting one or more quarters of the udder.


The increasing incidence of bovine mastitis and technological advancements in mastitis detection are expected to drive significant growth in the market. However, obstacles such as antibiotic resistance and high treatment costs may impede market expansion.


Furthermore, the global bovine mastitis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Type Analysis


The Global Bovine Mastitis Market is segmented among Clinical Mastitis, and Sub-clinical Mastitis, based on Type. In 2023, Sub-clinical Mastitis accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Product Analysis


The Global Bovine Mastitis Market is segmented among Antibiotics, Surgery, Vaccines, Pain Killers, and Other Products, based on Product. In 2023, Antibiotics accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Bovine Mastitis Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Elanco (Bayer AG), Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, and Advanced Animal Diagnostics.


 Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Bovine Mastitis Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Bovine Mastitis Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Bovine Mastitis Market Segmentation, By Type

  • Global Bovine Mastitis Market Share Analysis, By Type

  • Global Bovine Mastitis Market Growth Analysis, By Type

  • Global Bovine Mastitis Market Trends, By Type

o Clinical Mastitis

o Sub-clinical Mastitis

6. Global Bovine Mastitis Market Segmentation, By Product

  • Global Bovine Mastitis Market Share Analysis, By Product

  • Global Bovine Mastitis Market Growth Analysis, By Product

  • Global Bovine Mastitis Market Trends, By Product

o Antibiotics

o Surgery

o Vaccines

o Pain Killers

o Other Products

7. Global Bovine Mastitis Market Segmentation, By Route of Administration

  • Global Bovine Mastitis Market Share Analysis, By Route of Administration

  • Global Bovine Mastitis Market Growth Analysis, By Route of Administration

  • Global Bovine Mastitis Market Trends, By Route of Administration

o Intra-mammary

o Systemic

8. Global Bovine Mastitis Market Segmentation, By Therapy

  • Global Bovine Mastitis Market Share Analysis, By Therapy

  • Global Bovine Mastitis Market Growth Analysis, By Therapy

  • Global Bovine Mastitis Market Trends, By Therapy

o Lactating Period

o Dry Period

9. Global Bovine Mastitis Market Segmentation, By End User

  • Global Bovine Mastitis Market Share Analysis, By End User

  • Global Bovine Mastitis Market Growth Analysis, By End User

  • Global Bovine Mastitis Market Trends, By End User

o Hospitals and Clinics

o Veterinary Centers

o Other End Users

10. Global Bovine Mastitis Market Segmentation, By Region

  • Global Bovine Mastitis Market Share Analysis, By Region

  • Global Bovine Mastitis Market Growth Analysis, By Region

  • Global Bovine Mastitis Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

11. Competitive Landscape

  • Zoetis Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Merck & Co. Inc.

  • Boehringer Ingelheim International GmbH

  • Elanco (Bayer AG)

  • Ceva

  • West Way Health

  • Norbrook

  • DeLaval

  • ImmuCell Corporation

  • Advanced Animal Diagnostics

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page